Traditionally, biopharma companies can increase their revenue for research and overhead through price increases for exclusively owned products. (First, raise the price on drugs you’ve got a patent for.... read more →
Last month, the U.S. Census Bureau and the U.S. Department of Housing and Urban Development announced the latest residential construction rates, demolishing economists’ expectations. Overall home construction is up... read more →